Previous 10 | Next 10 |
Shares of Vaxart (NASDAQ: VXRT) were skyrocketing 26.4% higher as of 11:22 a.m. EDT on Monday. The huge jump came after investment bank B. Riley FBR initiated coverage on the stock with a buy rating and a price target of $22. This price target represented a 176% premium over Vaxart's closing...
July 13, 2020 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – July 13, 2020 – Coronavirus cases continue to rise in the US this month as regulations lift, causing overambitious governors in several states to backpedal on previous cl...
Before the pandemic, most healthcare investors had probably never heard of the vaccine biotech Vaxart (NASDAQ: VXRT) . At the end of 2019, Vaxart's market cap was a minuscule $16.9 million, a far cry from the nearly $700 million it has reached today. Because of the pandemic, however, Vaxart's...
The following medical companies have filed for mixed shelf offerings: More news on: Ardelyx, Inc., Vaxart, Inc., Alpine Immune Sciences, Inc., Healthcare stocks news, , Read more ...
Let's talk about two companies developing COVID-19 vaccines that are much different from the ones we're generally used to. These two aren't going the traditional route of injecting a weakened version of the pathogen into the body. They have new ways of addressing the problem. You've probably he...
Vaxart (NASDAQ: VXRT) , a biotech company focused on the development of oral vaccines, had an underwhelming performance in the stock market in 2019 with its shares dropping by more than 80%. But largely thanks to the company's efforts to develop a vaccine for COVID-19, the stock has soared by...
Biotech Stocks Are On The Rise Amid News From Novavax When we hear the term coronavirus stocks , it can refer to a broad range of sectors. Depending on the context, it could be the new-economy stocks, spanning from gaming companies and online food delivery to biotech stocks . Like it or not,...
The race for a coronavirus vaccine is heating up. Operation Warp Speed is giving resources to small companies. Novavax (NVAX), Inovio (INO), Moderna (MRNA), Vaxart (VXRT), and VBI Vaccines (VBIV) are the current leaders. Currently, vaccine candidates for the coronavirus are in various stag...
July 8, 2020 Palm Beach, FL – July 8, 2020 – The entire global medical community has focused on finding treatments and vaccines to defeat the current global health crisis. Some treatments are showing signs of helping patients survive but a vaccine is the “Holy...
A COVID-19 vaccine will be worth billions and billions of dollars. It will likely be the most valuable drug on the planet. There are many pharmaceutical companies are pursuing a vaccine, and the market has already started rewarding some of them. Right now the big winners are small-cap biotech va...
News, Short Squeeze, Breakout and More Instantly...
Vaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23% at one point. Vaxart’s average session v...
Shares of Adobe Inc. (NASDAQ:ADBE) rose sharply in today's pre-market trading following better-than-expected second-quarter earnings and stron...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...